Bolt Biotherapeutics (BOLT) EBT Margin (QoQ) (2020 - 2026)
Bolt Biotherapeutics (BOLT) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Bolt Biotherapeutics | 5.88 Mn | 5.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -59.68 Mn |
| Mar 31, 2026 | -3.29 Mn |
| Dec 31, 2025 | 150,468.00 |
| Sep 30, 2025 | 52,295.00 |
| Jun 30, 2025 | -136,347.00 |
| Sep 30, 2024 | 22,482.00 |
| Jun 30, 2024 | -136,627.00 |
| Mar 31, 2024 | 25,038.00 |
| Dec 31, 2023 | 136,673.00 |
| Sep 30, 2023 | 167,913.00 |
| Jun 30, 2023 | -86,926.00 |
| Mar 31, 2023 | -121,984.00 |
| Dec 31, 2022 | 121,203.00 |
| Sep 30, 2022 | 144,549.00 |
| Jun 30, 2022 | -74,870.00 |
| Mar 31, 2022 | 227,375.00 |
| Dec 31, 2021 | 266,318.00 |
| Jun 30, 2020 | -1.30 Mn |